Your cart is empty now.
PNRECOV
A novel nutraceutical analgesic
A Step to ensure Pain does not return
A Step to ensure Pain does not return
Composition:
Commiphora 150 mg, Boswellia Serrata 150 mg, Curcumin 125 mg, Syzgium aromaticum extract (β Caryophyllene) 100 mg, Uridine monophosphate 25 mg, Vitamin B6 1.2 mg, L-methyl Folate 150 mcg, Cyanocobalamin (Vitamin B12 1 mcg Tablets)
Dosage:
1-2 tablets per day
Based on the severity of symptoms
Indications:
In the management of pain and inflammation
- Pain associated with various musculoskeletal disorders
- Neuropathic pain
- General pain
- Inflammation due to oxidative stress
- Fatigue
What is it for?
- A novel nutraceutical analgesic
- Synergistic action of clinically proven ingredients that blocks multiple pain triggering factors
- Reduces inflammation and pain
- Reduces oxidative stress
- Prevents neuropathy
- Well Tolerated
Benefits of Ingredients
- C. myrrha – Blocks µ opioid receptors, Blocks COX, NO formation, ROS, TNFα, PGE2, NFKβ, MAPK Mediators
- Curcumin + B. Serrata – Blocks NFKβ pathway, Blocks prostaglandin pathway
- β Caryophyllene in S. aromaticum extract– Blocks CB2, Cannabinoid receptors
- Uridine / methyl folate / Vitamin B6 / B12 – Nerve cell repair, Recovery of motor and sensor functions
- Combination of above ingredients targeting various pain pathway will be effective in management of acute and chronic musculoskeletal pains.
The Evidence
Clinical evidence of Commiphora myrrha in treatment of chronic low back pain
An open label pilot study that demonstrated the efficacy of C. myrrha extract capsules in 204 Indian patients suffering from chronic low back pain. A significant pain reduction was observed from the 7 th day of treatment.
Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the Osteoarthritis
A randomized, placebo-controlled, double-blind trial with 201 patients of Osteoarthritis(OA) treated with Curcumin with that of Curcumin + Boswellia extract and placebo.
Efficacy of β- caryophyllene in delayed onset muscle soreness (DOMS) treatment
Efficacy of Syzygium aromaticum extract (standardized with β- caryophyllene) was confirmed with a randomized, double-blinded, crossover-designed, placebo-controlled study, conducted on 20 participants suffering from delayed onset muscle soreness (DOMS).
Role of Uridine and B Vitamins in treatment of Neuropathic pain
Uridine monophosphate (UMP)+Folic acid + Vitamin B12 supplementation in 212 patients of Neuropathic pain & Peripheral neuropathy; statistically significant reductions was observed not only in the total Pain detect questionnaire (PDQ) score
Translation missing: en.general.search.loading